1. Market Research
  2. > Healthcare Market Trends
  3. > Mexico General Surgery Outlook to 2020

Mexico General Surgery Outlook to 2020

  • July 2014
  • -
  • GlobalData
  • -
  • 301 pages

Summary

Table of Contents

Search Inside

Mexico General Surgery Outlook to 2020

Summary

GlobalData’s new report, "Mexico General Surgery Outlook to 2020", provides key market data on the Mexico General Surgery Procedures. The report provides procedure volumes within market segments - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- General Surgery procedure volumes by category - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.
- Projections for each of the market categories. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

  • $ 6995
  • Industry report
  • March 2017
  • by GBI Research

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products Summary Fatty liver disease (FLD) comprises a spectrum of chronic ...

North America Computed Tomography (CT) Systems Market Outlook to 2022

North America Computed Tomography (CT) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

North America Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "North America Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data ...

Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.